Sectors Up Close: AI ‘could improve drugmaker revenues by 12%’ featuring Leah Bennett

August 4, 2025

The healthcare sector has trailed behind other stocks this year, as drugmakers like Ozempic maker Novo Nordisk and Eli Lilly have found themselves in fierce competition with each other over the obesity drug market.

Leah Bennett of Concurrent Asset Management told Reuters AI could shrink the cost of clinical trials and bring many more medicines onto the market — leading to a rush of M&A in the biotech sector.

 

Source: Reuters

Share

More Posts